We are monitoring the current outbreak of Coronavirus Disease 2019 (COVID-19) very closely, while following updates and guidance from the World Health Organization.

Every precaution is being taken to ensure the health and safety of our entire DIA family.
Learn More
INSIDER ACCESS: DIA Member Exclusive

Artificial Intelligence in Drug Discovery and Development: Watch the video, follow the interactive transcript, or download the audio to learn on the go.
Start Exploring
DIA DEEP DIVE: COVID-19 Vaccines

US NIH begins clinical trial of investigational vaccine for COVID-19 to evaluate safety and ability to induce immune response. What other vaccines are in process?
Start Exploring
New Advanced Therapy Community Launching in June

New global DIA community creates forum for cross-functional discussion from experimental inception through marketed use of these novel products
Read Now
PODCAST: ATMPs May Deliver on Promise of Individualized Medicine

ATMPs will help introduce truly transformational products that differentiate individualized from personalized medicine
Listen Now
DIA NOW delivering Always-On Insights

Making the intersection of healthcare accessible anytime, anywhere, across any device. NEW Pharmacovigilance and Safety content!
Start Exploring
How Does DIA Membership Benefit You?
Connect with global influencers, and uncover ways to deliver impactful change
Access new knowledge that keeps you on the cutting-edge of healthcare conversations
Advance career development goals through best-in-class learning programs
Open doors to new pathways towards leadership growth
Expand your network to include global peers who support one another in real time
Christi Marsh
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Christi Marsh
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Global Forum, DIA's Digital Magazine
Uncover expert insights through global and regional coverage of the discovery, development, regulation, surveillance, and marketing of healthcare products, including interviews with thought leaders and topical summaries from educational events.
DIA's Podcast Channel
Get inside the minds of life science leaders as they share perspectives on current issues in healthcare product development, and the potential paths that lie ahead.